Chandrakant R. Kokare

Pune, MH, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Corrigendum to "Antipsychotic potential and safety profile of TPGS-based mucoadhesive aripiprazole nanoemulsion: Development and optimization for nose-to-brain delivery" [Journal of Pharmaceutical Sciences 110/4 (2021) 1761-1778].

Corrigendum to "Antipsychotic potential and safety profile of TPGS-based mucoadhesive aripiprazole nanoemulsion: Development and optimization for nose-to-brain delivery" [Journal of Pharmaceutical Sciences 110/4 (2021) 1761-1778].

Journal: Journal of pharmaceutical sciences

Published: June 18, 2026

Corrigendum to "Nose-to-brain delivery of sorafenib-loaded lipid-based poloxamer-carrageenan nanoemulgel: Formulation and therapeutic investigation in glioblastoma-induced orthotopic rat model" [Int. J. Biol. Macromol. 309 (2025) 142861].

Corrigendum to "Nose-to-brain delivery of sorafenib-loaded lipid-based poloxamer-carrageenan nanoemulgel: Formulation and therapeutic investigation in glioblastoma-induced orthotopic rat model" [Int. J. Biol. Macromol. 309 (2025) 142861].

Journal: International journal of biological macromolecules

Published: March 11, 2026

QbD-enabled formulation development of imatinib using self-nanoemulsifying drug delivery system in nose-to-brain treatment of Glioblastoma.

QbD-enabled formulation development of imatinib using self-nanoemulsifying drug delivery system in nose-to-brain treatment of Glioblastoma.

Journal: International journal of pharmaceutics

Published: September 17, 2025

Thermosensitive in situ gel powered by pectin-chitosan nanocapsules for intraocular delivery of acetazolamide: in vitro, ex vivo, and in vivo evaluation.

Thermosensitive in situ gel powered by pectin-chitosan nanocapsules for intraocular delivery of acetazolamide: in vitro, ex vivo, and in vivo evaluation.

Journal: Drug delivery and translational research

Published: June 24, 2025

Nanotechnology-based advancements in Parkinson's therapy: Exploring animal models and clinical insights in neurodegenerative disorders.

Nanotechnology-based advancements in Parkinson's therapy: Exploring animal models and clinical insights in neurodegenerative disorders.

Journal: Ageing research reviews

Published: February 06, 2025

Nose-to-brain delivery of sorafenib-loaded lipid-based poloxamer-carrageenan nanoemulgel: Formulation and therapeutic investigation in glioblastoma-induced orthotopic rat model.

Nose-to-brain delivery of sorafenib-loaded lipid-based poloxamer-carrageenan nanoemulgel: Formulation and therapeutic investigation in glioblastoma-induced orthotopic rat model.

Journal: International journal of biological macromolecules

Published: December 04, 2024

Fabrication of acetazolamide loaded leciplex for intraocular delivery: Optimization by 32 full factorial design, in vitro, ex vivo and in vivo pharmacodynamics.

Fabrication of acetazolamide loaded leciplex for intraocular delivery: Optimization by 32 full factorial design, in vitro, ex vivo and in vivo pharmacodynamics.

Journal: International journal of pharmaceutics

Published: May 09, 2024

Corrigendum to "Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis" [Brain Res. 1822 (2023) 148674].

Corrigendum to "Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis" [Brain Res. 1822 (2023) 148674].

Journal: Brain research

Published: March 15, 2024

Fabrication of architectonic nanosponges for intraocular delivery of Brinzolamide: An insight into QbD driven optimization, in vitro characterization, and pharmacodynamics.

Fabrication of architectonic nanosponges for intraocular delivery of Brinzolamide: An insight into QbD driven optimization, in vitro characterization, and pharmacodynamics.

Journal: International journal of pharmaceutics

Published: September 01, 2023

Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis.

Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis.

Journal: Brain research

Published: April 25, 2023

Nose-to-brain delivery of octreotide acetate in situ gel for pituitary adenoma: Pharmacological and in vitro cytotoxicity studies.

Nose-to-brain delivery of octreotide acetate in situ gel for pituitary adenoma: Pharmacological and in vitro cytotoxicity studies.

Journal: International journal of pharmaceutics

Published: July 20, 2022

Nose-to-brain delivery of paliperidone palmitate poloxamer-guar gum nanogel: Formulation, optimization and pharmacological studies in rats.

Nose-to-brain delivery of paliperidone palmitate poloxamer-guar gum nanogel: Formulation, optimization and pharmacological studies in rats.

Journal: Annales pharmaceutiques francaises

Published: March 24, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026